ArticleNucleic acids research2026
DNA induces non-canonical dimerization of the farnesoid X receptor.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The farnesoid X receptor (FXR) is a ligand-regulated transcription factor that primarily functions as an obligate heterodimer with retinoid X receptor alpha (RXRα). While evidence suggests that FXR can also bind DNA independently, the nature of this interaction and the characteristics of the resulting complex remain unknown. Using purified multidomain FXR containing the DNA and ligand binding domains linked by the hinge, we present the first biophysical and structural characterization of FXR bound to DNA independently of RXR. Our findings reveal that DNA binding promotes the assembly of two FXR monomers into a complex capable of binding coregulators and activating transcription from an FXR DNA binding motif. By comparing the FXR-DNA complex with the multidomain FXR-RXRα heterodimer, we uncover key structural and functional differences between the complexes. Small-angle X-ray scattering (SAXS) analysis shows that the FXR-DNA complex adopts a uniquely extended conformation, in which the two ligand-binding domains are non-interacting, with a dimer interface on the DNA-binding domains. By characterizing this newly identified oligomeric state of FXR, our study reveals a novel architectural motif with broad implications for its transcriptional function.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.